论文部分内容阅读
目的:观察子宫腺肌病应用单纯子宫腺肌病病灶切除术后联合促性腺激素释放激素激动剂治疗的临床效果。方法:随机选取我院于2010年10月~2012年10月收治的60例子宫腺肌病患者分为观察组与对照组,对照组患者单纯进行子宫腺肌病病灶切除术,观察组患者在此基础上进行促性腺激素释放激素激动剂治疗,观察并比较2组患者的治疗效果。结果:治疗结束后,2组患者的痛经视觉模拟评分都有明显降低,观察组患者评分下降较明显,与对照组比较差异有统计学意义(P<0.05)。观察组患者的复发率为10%,较对照组36.7%的复发率低,比较差异有统计学意义(P<0.05)。结论:子宫腺肌病应用单纯子宫腺肌病病灶切除术后联合促性腺激素释放激素激动剂治疗有着良好的临床效果,且复发率低,可以在临床上广泛推广。
Objective: To observe the clinical effect of combined gonadotropin-releasing hormone agonist therapy in patients with adenomyosis after resection of adenomyosis. Methods: 60 cases of adenomyosis randomly selected from our hospital from October 2010 to October 2012 were divided into observation group and control group. Patients in the control group were treated with adenomyosis resection alone. Patients in observation group were treated with On the basis of gonadotropin-releasing hormone agonist treatment, observation and comparison of two groups of patients treatment. Results: After the treatment, visual analog scale of dysmenorrhea was significantly decreased in both groups. The score of observation group was significantly lower than that of control group (P <0.05). The recurrence rate of the observation group was 10%, which was lower than that of the control group (36.7%), the difference was statistically significant (P <0.05). Conclusion: Adenomyosis alone adenomyosis after focal excision combined with gonadotropin-releasing hormone agonist therapy has a good clinical effect, and the recurrence rate is low, it can be widely promoted in the clinic.